ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2026

Corrigendum to "Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancer": [Ann Oncol 36 (2025) 76-88].

D E Rathkopf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.